01 1Apicore
01 1BORTEZOMIB
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-01-22
Pay. Date : 2013-09-20
DMF Number : 22922
Submission : 2009-06-30
Status : Active
Type : II
20
Apicore Us Llc, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is BORTEZOMIB, with a corresponding US DMF Number 22922.
Remarkably, this DMF maintains an Active status since its submission on June 30, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 22, 2014, and payment made on September 20, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
